Patents by Inventor Kelly L. Wassarman

Kelly L. Wassarman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytosine-based TET enzyme inhibitors
    Patent number: 11504369
    Abstract: Provided herein, in some embodiments, are cytosine analogs, compositions comprising cytosine analogs, and methods of use for inhibiting a Ten-eleven translocation (TET) enzyme.
    Type: Grant
    Filed: March 20, 2020
    Date of Patent: November 22, 2022
    Assignee: President and Trustees of Bates College
    Inventors: Andrew Kennedy, Gabriella N. L. Chua, Kelly L. Wassarman, Haoyu Sun
  • CYTOSINE-BASED TET ENZYME INHIBITORS
    Publication number: 20200316069
    Abstract: Provided herein, in some embodiments, are cytosine analogs, compositions comprising cytosine analogs, and methods of use for inhibiting a Ten-eleven translocation (TET) enzyme.
    Type: Application
    Filed: March 20, 2020
    Publication date: October 8, 2020
    Inventors: Andrew Kennedy, Gabriella N. L. Chua, Kelly L. Wassarman, Haoyu Sun